{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:58:28Z","timestamp":1788328708817,"version":"build-2803163510"},"reference-count":58,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2019,9,3]]},"DOI":"10.18632\/aging.102221","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:29:38Z","timestamp":1567538978000},"page":"6915-6929","source":"Crossref","is-referenced-by-count":76,"title":["Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain"],"prefix":"10.18632","volume":"11","author":[{"given":"Yaoyu","family":"Pu","sequence":"first","affiliation":[{"name":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youge","family":"Qu","sequence":"additional","affiliation":[{"name":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba 260-8670, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention.","volume":"1","author":"Schwarzschild","year":"2016","journal-title":"Lancet Neurol"},{"key":"2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease.","volume":"38","author":"Lang","year":"2015","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/mds.27741","article-title":"Changing views of the pathophysiology of Parkinsonism.","volume":"3","author":"Wichmann","year":"2019","journal-title":"Mov Disord"},{"key":"4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","article-title":"Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression.","volume":"4","author":"Scheperjans","year":"2019","journal-title":"EBioMedicine"},{"key":"5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14802\/jmd.18067","article-title":"Altered Gut Microbiome and Intestinal Pathology in Parkinson\u2019s Disease.","volume":"1","author":"Lin","year":"2019","journal-title":"J Mov Disord"},{"key":"6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1113\/JP273106","article-title":"Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration.","volume":"59","author":"Cryan","year":"2017","journal-title":"J Physiol"},{"key":"7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.012","article-title":"Microbiota-gut-brain signalling in Parkinson\u2019s disease: implications for non-motor symptoms.","volume":"2","author":"O\u2019Mahony","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbi.2017.06.017","article-title":"Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases.","volume":"6","author":"Ribatti","year":"2017","journal-title":"Brain Behav Immun"},{"key":"9","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.3748\/wjg.v21.i37.10609","article-title":"Brain-gut-microbiota axis in Parkinson\u2019s disease.","volume":"2","author":"Bonaz","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.002","article-title":"Gut microbiota: implications in Parkinson\u2019s disease.","volume":"3","author":"Udayabanu","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype.","volume":"3","author":"Auvinen","year":"2015","journal-title":"Mov Disord"},{"key":"12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/WCO.0000000000000389","article-title":"Gut microbiota, 1013 new pieces in the Parkinson\u2019s disease puzzle.","volume":"2","author":"Scheperjans","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"13","doi-asserted-by":"publisher","first-page":"e0208313","DOI":"10.1371\/journal.pone.0208313","article-title":"Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson\u2019s disease.","volume":"1","author":"Ohno","year":"2018","journal-title":"PLoS One"},{"key":"14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jnnp-2015-311680","article-title":"Constipation preceding Parkinson\u2019s disease: a systematic review and meta-analysis.","volume":"8","author":"Noyce","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"15","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00213-019-5185-8","article-title":"Psychotropics and the Microbiome: a Chamber of Secrets\u2026.","volume":"23","author":"Cryan","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.yfrne.2018.04.002","article-title":"The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective.","volume":"5","author":"Cryan","year":"2018","journal-title":"Front Neuroendocrinol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00213-018-5006-5","article-title":"Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function.","volume":"23","author":"Cryan","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12916-016-0604-8","article-title":"Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?","volume":"1","author":"Bienenstock","year":"2016","journal-title":"BMC Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","article-title":"Interactions between the microbiota, immune and nervous systems in health and disease.","volume":"2","author":"Hsiao","year":"2017","journal-title":"Nat Neurosci"},{"key":"20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.annepidem.2016.02.008","article-title":"Brain-gut-microbiota axis: challenges for translation in psychiatry.","volume":"2","author":"Dinan","year":"2016","journal-title":"Ann Epidemiol"},{"key":"21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12974-019-1434-3","article-title":"Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis.","volume":"1","author":"Wang","year":"2019","journal-title":"J Neuroinflammation"},{"key":"22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/FBP.0000000000000478","article-title":"Stress and the gut microbiota-brain axis.","volume":"3","author":"Cardona","year":"2019","journal-title":"Behav Pharmacol"},{"key":"23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease.","volume":"9","author":"Mazmanian","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbi.2018.12.014","article-title":"Antibiotics and the nervous system: more than just the microbes?","volume":"7","author":"McVey Neufeld","year":"2019","journal-title":"Brain Behav Immun"},{"key":"25","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","article-title":"Antibiotics as deep modulators of gut microbiota: between good and evil.","volume":"6","author":"Gasbarrini","year":"2016","journal-title":"Gut"},{"key":"26","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1128\/IAI.01520-08","article-title":"Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation.","volume":"7","author":"Young","year":"2009","journal-title":"Infect Immun"},{"key":"27","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2016.04.003","article-title":"Antibiotic-Induced Changes in the Intestinal Microbiota and Disease.","volume":"2","author":"Pamer","year":"2016","journal-title":"Trends Mol Med"},{"key":"28","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1038\/tp.2013.83","article-title":"Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat.","volume":"3","author":"O\u2019Mahony","year":"2013","journal-title":"Transl Psychiatry"},{"key":"29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/ismej.2007.3","article-title":"Long-term ecological impacts of antibiotic administration on the human intestinal microbiota.","volume":"1","author":"Jansson","year":"2007","journal-title":"ISME J"},{"key":"30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/imr.12563","article-title":"The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.","volume":"27","author":"Pamer","year":"2017","journal-title":"Immunol Rev"},{"key":"31","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1128\/JCM.42.3.1203-1206.2004","article-title":"Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota.","volume":"4","author":"Schmidt","year":"2004","journal-title":"J Clin Microbiol"},{"key":"32","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1038\/s41467-018-05336-9","article-title":"Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.","volume":"9","author":"Panda","year":"2018","journal-title":"Nat Commun"},{"key":"33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41398-019-0379-8","article-title":"Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain.","volume":"9","author":"Hashimoto","year":"2019","journal-title":"Transl Psychiatry"},{"key":"34","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.18632\/aging.101464","article-title":"Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice.","volume":"1","author":"Luo","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"35","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/cns.13103","article-title":"Abnormal composition of gut microbiota contributes to delirium-like behaviors after abdominal surgery in mice.","volume":"2","author":"Luo","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"36","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease.","volume":"16","author":"Shannon","year":"2016","journal-title":"Cell"},{"key":"37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease.","volume":"2","author":"Przedborski","year":"2007","journal-title":"Nat Protoc"},{"key":"38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.celrep.2018.12.028","article-title":"Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids.","volume":"2","author":"Liu","year":"2019","journal-title":"Cell Rep"},{"key":"39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1365-2249.2010.04286.x","article-title":"Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition.","volume":"16","author":"Tlaskalova-Hogenova","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"40","doi-asserted-by":"publisher","first-page":"e7247","DOI":"10.1371\/journal.pone.0007247","article-title":"Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease.","volume":"4","author":"Noda","year":"2009","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"publisher","first-page":"22525","DOI":"10.1038\/srep22525","article-title":"Integrated metabolomics and metagenomics analysis of plasma and urine identified microbial metabolites associated with coronary heart disease.","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"42","doi-asserted-by":"publisher","first-page":"17579","DOI":"10.1074\/jbc.M112.434787","article-title":"A blood-brain barrier (BBB) disrupter is also a potent \u03b1-synuclein (\u03b1-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD).","volume":"28","author":"Gazit","year":"2013","journal-title":"J Biol Chem"},{"key":"43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fmolb.2019.00016","article-title":"Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of \u03b1-Synuclein Amyloids in Parkinson\u2019s Disease.","volume":"6","author":"Segal","year":"2019","journal-title":"Front Mol Biosci"},{"key":"44","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3389\/fimmu.2018.01830","article-title":"Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer.","volume":"9","author":"Chifiriuc","year":"2018","journal-title":"Front Immunol"},{"key":"45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway.","volume":"7","author":"Shen","year":"2018","journal-title":"Brain Behav Immun"},{"key":"46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.imbio.2012.07.033","article-title":"IgA production in the large intestine is modulated by a different mechanism than in the small intestine: bacteroides acidifaciens promotes IgA production in the large intestine by inducing germinal center formation and increasing the number of IgA+ B cells.","volume":"21","author":"Kaminogawa","year":"2013","journal-title":"Immunobiology"},{"key":"47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/mi.2016.42","article-title":"Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice.","volume":"1","author":"Kwon","year":"2017","journal-title":"Mucosal Immunol"},{"key":"48","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1460-9568.2006.04610.x","article-title":"H MRS identifies lactate rise in the striatum of MPTP-treated C57BL\/6 mice.","volume":"2","author":"Nakai","year":"2006","journal-title":"Eur J Neurosci"},{"key":"49","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neuron.2018.11.018","article-title":"Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder.","volume":"10","author":"Costa-Mattioli","year":"2019","journal-title":"Neuron"},{"key":"50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.chom.2018.11.016","article-title":"Dietary fructose and microbiota-derived short-chain fatty acids promote bacteriophage production in the gut symbiont Lactobacillus reuteri.","volume":"2","author":"van Pijkeren","year":"2019","journal-title":"Cell Host Microbe"},{"key":"51","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1084\/jem.20151345","article-title":"Gut dysbiosis impairs recovery after spinal cord injury.","volume":"21","author":"Popovich","year":"2016","journal-title":"J Exp Med"},{"key":"52","doi-asserted-by":"publisher","first-page":"E113","DOI":"10.3390\/brainsci8060113","article-title":"A Review of Traumatic Brain Injury and the Gut Microbiome: Insights into Novel Mechanisms of Secondary Brain Injury and Promising Targets for Neuroprotection.","volume":"8","author":"Nicholson","year":"2018","journal-title":"Brain Sci"},{"key":"53","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s41598-018-19646-x","article-title":"Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice.","volume":"8","author":"Oh","year":"2018","journal-title":"Sci Rep"},{"key":"54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jnutbio.2019.03.021","article-title":"Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity.","volume":"6","author":"Choi","year":"2019","journal-title":"J Nutr Biochem"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12060","article-title":"Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP.","author":"Hashimoto","year":"2019","journal-title":"Neuropsychopharmacol Rep"},{"key":"56","doi-asserted-by":"publisher","first-page":"E5815","DOI":"10.1073\/pnas.1802179115","article-title":"Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson\u2019s disease.","volume":"11","author":"Hashimoto","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"57","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/dnares\/dst006","article-title":"Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing.","volume":"2","author":"Hattori","year":"2013","journal-title":"DNA Res"},{"key":"58","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","article-title":"A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.","volume":"56","author":"Yasuma-Mitobe","year":"2019","journal-title":"Nature"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:15:18Z","timestamp":1599074118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":58,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,9,15]]}},"alternative-id":["102221","31479418"],"URL":"https:\/\/doi.org\/10.18632\/aging.102221","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]}}}